McKesson Corp (MCK) stock
MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3027% above fair value
$1084.43−7.24 (-0.66%)
Close on Nov 18, 2026Market cap $126.43BP/E 29.0Yield 0.29%
McKesson net income
Net income is the profit left for shareholders after every expense, interest and tax.
McKesson's net income for the twelve months ending Jun 30, 2026 was $4.59B, up 45.1% year over year. For fiscal 2026 it was $4.76B, up 44.5% from the year before. Over ten years it grew 7.7% a year on average. The highest annual figure on record is $5.07B in fiscal 2017.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $4.76B | +44.5% |
| FY2025 | Mar 31, 2025 | $3.30B | +9.8% |
| FY2024 | Mar 31, 2024 | $3.00B | -15.7% |
| FY2023 | Mar 31, 2023 | $3.56B | +219.6% |
| FY2022 | Mar 31, 2022 | $1.11B | – |
| FY2021 | Mar 31, 2021 | -$4.54B | -604.3% |
| FY2020 | Mar 31, 2020 | $900.00M | +2547.1% |
| FY2019 | Mar 31, 2019 | $34.00M | -49.3% |
| FY2018 | Mar 31, 2018 | $67.00M | -98.7% |
| FY2017 | Mar 31, 2017 | $5.07B | +124.5% |
| FY2016 | Mar 31, 2016 | $2.26B | +53.0% |
| FY2015 | Mar 31, 2015 | $1.48B | +16.9% |
| FY2014 | Mar 31, 2014 | $1.26B | -5.6% |
| FY2013 | Mar 31, 2013 | $1.34B | -4.6% |
| FY2012 | Mar 31, 2012 | $1.40B | +16.7% |
| FY2011 | Mar 31, 2011 | $1.20B | -4.8% |
| FY2010 | Mar 31, 2010 | $1.26B | +53.5% |
| FY2009 | Mar 31, 2009 | $823.00M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $614.00M | -21.7% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $1.68B | +33.5% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $1.19B | +34.9% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $1.11B | +360.6% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $784.00M | -14.3% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $1.26B | +59.3% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $879.00M | +49.2% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $241.00M | -63.7% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $915.00M | -4.5% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $791.00M | +0.5% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $589.00M | -45.4% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $664.00M | -28.3% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $958.00M | +24.7% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $787.00M | +113.9% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $1.08B | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $926.00M | +246.8% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $768.00M | +58.0% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $368.00M | -44.7% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$7.00M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $267.00M | -53.7% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $486.00M | +9.5% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $666.00M | -34.8% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$6.23B | -3447.3% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $577.00M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $444.00M | +5.0% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $1.02B | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $186.00M | -60.3% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$730.00M | -246.3% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $423.00M | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$796.00M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $469.00M | -48.1% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $499.00M | +49800.0% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$138.00M | -144.7% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$1.15B | -131.9% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $903.00M | +42.7% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $1.00M | -99.7% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $309.00M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $3.59B | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $633.00M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $307.00M | – |
See a number that looks wrong?